ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Pittsburgh, PA, USA:

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development

Pittsburgh, Pennsylvania, United States and 4 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

AbbVie
AbbVie

Pittsburgh, Pennsylvania, United States and 49 other locations

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

Pittsburgh, Pennsylvania, United States and 13 other locations

with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...

Active, not recruiting
Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Dexamethasone
Drug: Venetoclax

Phase 1

Pfizer
Pfizer

Pittsburgh, Pennsylvania, United States and 61 other locations

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting
Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma (MZL)
Biological: Epcoritamab

Phase 1, Phase 2

Genmab
Genmab

Pittsburgh, Pennsylvania, United States and 84 other locations

1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for whic...

Enrolling
Solid Tumor, Adult Lymphoma
Drug: CYC140

Phase 1, Phase 2

Cyclacel Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 4 other locations

inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor ac...

Active, not recruiting
T-cell Lymphoma
Drug: CPI-818

Phase 1

Corvus Pharmaceuticals
Corvus Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 21 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Enrolling
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Pittsburgh, Pennsylvania, United States and 226 other locations

of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...

Enrolling
Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma
Drug: Cyclophosphamide
Genetic: ALLO-501A

Phase 1, Phase 2

Allogene Therapeutics

Pittsburgh, Pennsylvania, United States and 38 other locations

This study in patients with relapsed/refractory follicular lymphoma who have undergone at least 3 lines of therapy. Patients will receive ab...

Active, not recruiting
Follicular Lymphoma
Drug: Abexinostat

Phase 2

Xynomic Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 14 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems